Kazia Therapeutics Limite... (KZIA)
NASDAQ: KZIA
· Real-Time Price · USD
8.04
-0.23 (-2.78%)
At close: Aug 15, 2025, 2:37 PM
-2.78% (1D)
| Bid | 7.88 |
| Market Cap | 4.62M |
| Revenue (ttm) | 2.48M |
| Net Income (ttm) | -26.78M |
| EPS (ttm) | -29.18 |
| PE Ratio (ttm) | -0.28 |
| Forward PE | -812 |
| Analyst | Strong Buy |
| Ask | 8.19 |
| Volume | 8,503 |
| Avg. Volume (20D) | 1,079,154 |
| Open | 7.88 |
| Previous Close | 8.27 |
| Day's Range | 7.88 - 8.05 |
| 52-Week Range | 2.86 - 39.05 |
| Beta | 2.65 |
About KZIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KZIA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KZIA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+39.53%
Kazia Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
+81.37%
Kazia Therapeutics shares are trading higher after the company announced it published preclinical data on paxalisib in the journal Molecular Cancer Therapeutics.
